Compex Technologies, Inc. (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 25, 2005

Compex Technologies, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Minnesota 0-9407 410985318
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
1811 Old Highway 8, New Brighton, Minnesota   55112
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   (651) 631-0590

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 1.01. Entry into a Material Definitive Agreement.

On May 24, 2005, Compex Technologies, Inc. entered into an Manufacturing Agreement with Bionicare, Inc., a manufacturer of devices for use in reducing pain and symptoms associated with osteoarthritis of the knee, under which Compex will manufacture products for sale and distribution by Bionicare. Under the Agreement, Bionicare is obligated to issue quarterly purchase orders to Compex for a twelve month period, beginning July 1, 2005, but only the first three months are binding. On May 25, 2005, Compex received a purchase order for approximately $2.9 million of product to be delivered in July, August, and September 2005.





Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Compex Technologies, Inc.
          
June 1, 2005   By:   Dan Gladney
       
        Name: Dan Gladney
        Title: Chief Executive Officer